NewsBenzingaMaxCyte第三季度每股收益(EPS)为$(0.05),好于预估的$(0.08);销售额为1015.2万美元,好于预估的748.1万美元 MaxCyte第三季度每股收益(EPS)为$(0.05),好于预估的$(0.08);销售额为1015.2万美元,好于预估的748.1万美元 Benzinga 2026.11.10 11:02 (GMT+0) Open on Benzinga Other news David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes Bernstein Maintains Market Perform on Tyson Foods, Raises Price Target to $72 Broadcom Stock Is Up Tuesday: AI Chip Diversification, Dec. 9 Earnings, Analyst Targets Bernstein Downgrades PepsiCo to Underperform, Lowers Price Target to $128 If You Invested $1000 In Humana Stock 20 Years Ago, You Would Have This Much Today What's Going On With Ouster Stock Tuesday?